MPO and acute respiratory distress syndrome: The treatment of senegenin can not only significantly improve LPS-stimulated pulmonary edema, coagulation and inflammation, but also reduce myeloperoxidase (MPO) activity and lung wet-to-dry weight ratio caused by Acute Lung Injury (ALI).